DNM1L and metabolic dysfunction-associated steatotic liver disease: Hesperetin reduced dynamin-related protein 1 (Drp1) expression, heightened the expression of mitochondrial fusion proteins known as mitofusin-2 and optic atrophy 1, while simultaneously suppressing the activity of fission protein 1 and preventing the progression of NAFLD (50).